(Circulation. 2008;118:1268-1275.)
© 2008 American Heart Association, Inc.
Pediatric Cardiology |
From the Department of Obstetrics and Gynecology, Fetal Medicine and Cardiology Unit (L.M.L., M.A.B.L., G.M.P.T., A.P.D., M.Z.) and Department of Pathology (R.S.), Hospital das Clínicas, and Department of Pathology, Heart Institute (V.D.A.), São Paulo University Medical School, São Paulo, Brazil. Dr Tavares is now at the Heart Institute of the São Paulo University Medical School, São Paulo, Brazil. Dr Damiano is now at the Department of Pediatrics, State University of Campinas, São Paulo, Brazil.
Correspondence to Dr Lilian M. Lopes, Fetal Cardiologist–HCFMUSP, Al. Santos, No. 211, cj1307, São Paulo, SP, Brazil 01419.000. E-mail lilianlopes{at}ecokid.com.br
Received August 19, 2007; accepted July 7, 2008.
Background— Fetal atrioventricular (AV) block is an uncommon lesion with significant mortality. Because of the rarity of this disorder, the natural course, extensive evaluation of untreated fetuses, and late follow-up remain unclear.
Methods and Results— Of the 116 consecutive cases of fetal AV block studied from 1988 to 2006, only 1 was terminated, and 75% were live births. Fifty-nine cases of AV block were associated with major structural heart disease, mainly left atrial isomerism (n=40), with only 26% of neonatal survivors. Of the 57 fetuses with normal cardiac anatomy, 41 (72%) were positive for maternal antinuclear antibodies, and 32 of these seropositive mothers did not receive any treatment. This untreated group had live-birth and 1-year infant survival rates of 93% and 90%, respectively. Five fetuses from seronegative mothers showed regression to sinus rhythm during pregnancy. The presence of major structural heart disease, hydrops, an atrial rate
120 bpm, and a ventricular rate
55 bpm were identified as risk factors for mortality. Logistic regression analysis of the whole group showed that the presence of structural heart disease was the only independent predictor of death (P<0.001).
Conclusions— This long-term study confirms that fetal AV block has a poor outcome when associated with structural heart disease and that spontaneous regression of AV block is possible in seronegative forms. The survival rate of >90% of our untreated patients with isolated forms of AV block raises concerns about any decision to intervene with immunosuppressive agents.
Related Article:
This article has been cited by other articles:
![]() |
E. T. Jaeggi, F. Golding, and E. D. Silverman Letter by Jaeggi et al Regarding Article, "Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred Sixteen Cases From a Single Institution" Circulation, May 26, 2009; 119(20): e539 - e539. [Full Text] [PDF] |
||||
![]() |
E. Marijon Letter by Marijon Regarding Article, "Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred Sixteen Cases From a Single Institution" Circulation, May 26, 2009; 119(20): e540 - e540. [Full Text] [PDF] |
||||
![]() |
L. M. Lopes, M. A. B. Lopes, M. Zugaib, A. P. Damiano, G. M. P. Tavares, V. D. Aiello, and R. Schultz Response to Letters Regarding Article, "Perinatal Outcome of Fetal Atrioventricular Block: One-Hundred Sixteen Cases From a Single Institution" Circulation, May 26, 2009; 119(20): e541 - e542. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |